6533b7d5fe1ef96bd1264f14

RESEARCH PRODUCT

Strategies for identifying dysplasia in Barrett's oesophagus

Angelika BehrensChristian EllOliver Pech

subject

medicine.medical_specialtyHistologybusiness.industryGeneral surgerySampling errormedicine.diseasedigestive systemTimely diagnosisdigestive system diseasesPathology and Forensic MedicineSurgeryDysplasiaBarrett's oesophagusMedicineSampling (medicine)Detection ratebusiness

description

Abstract Early neoplastic changes in Barrett's oesophagus are often only recognizable visually as discrete mucosal irregularities. With timely diagnosis, the prognosis is excellent, in contrast to advanced tumours in Barrett's oesophagus. The international specialist societies therefore recommend regular endoscopic surveillance for patients who have been diagnosed with Barrett's oesophagus. Following the 1993 Seattle Protocol, the various guidelines consistently require four-quadrant biopsy sampling every 1–2 cm over the entire Barrett's segment and additional biopsies from visually suspicious-appearing areas. This approach is time-consuming and costly, and inevitably involves sampling errors. Constant improvements in the image quality of modern endoscopes in recent years have made a vital contribution to increasing the detection rate of early neoplastic changes in Barrett's oesophagus. The aim of new technological developments is to increase the detection rate further. This article reviews the current state of technological developments and assesses their value.

https://doi.org/10.1016/j.mpdhp.2012.10.001